英文别名 |
Desogestrel;13-ethyl-11-methylene-19-dinorpregn-4-en-20-yn-17-o(17-alpha)-1;org2969;13-ethyl-11-methylene-18,19-dinor-17alpha-pregn-4-en-20-yn-17-ol;(17a)-13-Ethyl-11-methylene-18,19-dinorpregn-4-en-20-yn-17-ol;Cerazette;Cyclosa;Dicromil;Org-2969;13-ethyl-11-methylene-18,19-dinor-17a-pregn-4-en-20-yn-17-ol;13-Ethyl-11-methylene-18,19-dinor-17α-4-pregnen-20-yn-17-ol;13-Ethyl-11-methylene-18,19-dinor-17α-pregn-4-en-20-yn-17-ol;320;DESOGESTRAL;Desogestrel(50Mg);Marvelon 150;Desogestrelum;desogen;Desogestrelum [INN-Latin];ORG 2969;C22H30O;81K9V7M3A3;DESOGESTREL COMPONENT OF VELIVET;NS00003854;PIMTREA COMPONENT DESOGESTREL;Mircette;DESOGESTREL [USP MONOGRAPH];ENSKYCE COMPONENT DESOGESTREL;DESOGESTREL [HSDB];C15951;CAS-54024-22-5;NCGC00167449-01;D4163;AS-13022;BCP18794;DESOGESTREL [MART.];DESOGESTREL [EP MONOGRAPH];BDBM50423510;DESOGESTREL [JAN];EN300-23839418;SR-01000883959-1;DESOGESTREL COMPONENT OF CYCLESSA;AKOS015963198;MFCD00869346;LMST02030104;VOLNEA COMPONENT DESOGESTREL;ISIBLOOM COMPONENT DESOGESTREL;VELIVET COMPONENT DESOGESTREL;VIORELE COMPONENT DESOGESTREL;Tox21_112453;C07629;(8S,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-11-methylidene-1,2,3,6,7,8,9,10,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-ol;(17alpha)-13-Ethyl-11-methylene-18,19-dinorpregn-4-en-20-yn-17-ol;CHEMBL1533;D02367;Desogestrel, United States Pharmacopeia (USP) Reference Standard;DESOGESTREL COMPONENT OF ORTHO-CEPT;DTXSID6022898;AC-308;17alpha-ethynyl-13beta-ethyl-11-methylene-4-gonen-17-ol;DESOGESTREL COMPONENT OF MIRCETTE;DESOGESTREL [USP-RS];UNII-81K9V7M3A3;RPLCPCMSCLEKRS-BPIQYHPVSA-N;SR-01000883959;DESOGEN COMPONENT DESOGESTREL;18,19-Dinorpregn-4-en-20-yn-17-ol, 13-ethyl-11-methylene-, (17alpha)-;DESOGESTREL [USAN];KARIVA COMPONENT DESOGESTREL;DESOGESTREL [INN];SR-01000883959-2;GTPL7065;Desogestrel, VETRANAL(TM), analytical standard;CHEBI:4453;s4638;MIRCETTE COMPONENT DESOGESTREL;Q415304;DESOGESTREL [VANDF];DTXCID702898;54024-22-5;EINECS 258-929-4;DESOGESTREL [MI];DB00304;DESOGESTREL [WHO-DD];13-ethyl-11-methylene-18,19-dinorpregn-4-en-20-yn-17alpha-ol;18,19-Dinorpregn-4-en-20-yn-17-ol, 13-ethyl-11-methylene-, (17.alpha.)-;HSDB 3593;Desogestrel, British Pharmacopoeia (BP) Reference Standard;Desogestrel [USAN:INN:BAN];ORTHO-CEPT COMPONENT DESOGESTREL;DESOGESTREL COMPONENT OF DESOGEN;CYCLESSA COMPONENT DESOGESTREL;DESOGESTREL [ORANGE BOOK];Desogestrel for system suitability, European Pharmacopoeia (EP) Reference Standard;SCHEMBL41341;Desogestrel 100 microg/mL in Acetonitrile;CS-3686;Desogestrel, European Pharmacopoeia (EP) Reference Standard;DESOGESTREL COMPONENT OF KARIVA;J-520217;Desogestrel, Pharmaceutical Secondary Standard; Certified Reference Material;(1R,3aS,3bS,9aR,9bS,11aS)-11a-ethyl-1-ethynyl-10-methylidene-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-1-ol;Desogestrel (USAN/INN);HY-12516;CCG-267585;BEKYREE COM... |